Myocardial fibrosis, the expansion of the cardiac interstitium through deposition of
extracellular matrix proteins, is a common pathophysiologic companion of many different …

Cardiac fibrosis is a common pathophysiologic companion of most myocardial diseases,
and is associated with systolic and diastolic dysfunction, arrhythmogenesis, and adverse …

Cardiac myofibroblasts play an important role in myocardial remodeling. Although α-smooth
muscle actin (α-SMA) expression is the hallmark of mature myofibroblasts, its role in …

Cardiac fibrosis is central to the pathology of heart failure, particularly heart failure with
preserved ejection fraction (HF p EF). Irrespective of the underlying profibrotic condition (eg …

Myocardial fibrosis (MF) plays a key role in the development and progression of heart failure
(HF) with limited effective therapies. Galectin-3 (Gal-3) is a biomarker associated with …

Cerebrovascular diseases such as ischemic stroke, brain hemorrhage, and subarachnoid
hemorrhage provoke cardiac complications such as heart failure, neurogenic stress-related …

Background—Galectin (Gal)-3 is a β-galactoside-binding lectin and currently intensely
studied as a biomarker in heart failure. Gal-3 also exerts proinflammatory effects, at least in …

Galectin-3 plays a prominent role in chronic inflammation and has been implicated in the
development of many disease conditions, including heart disease. Galectin-3, a regulatory …

Purpose Several studies have reported that colchicine attenuates cardiac inflammation and
improves cardiac function in myocardial infarction and atrial fibrillation. However, no study …

Background A high proportion of patients undergoing catheter ablation (CA) for atrial
fibrillation (AF) experience recurrence of arrhythmia. This meta-analysis aims to identify pre …